Rhode Island 2022 Regular Session

Rhode Island Senate Bill S2611

Introduced
3/10/22  

Caption

Opioid Alternatives

Impact

The proposed legislation would directly amend Title 23 of the General Laws to introduce a new chapter dedicated to opioid alternatives. This chapter would not only outline educational mandates but also potentially reshape the dynamics of pain management within the state. By requiring healthcare practitioners to discuss and document the use of opioid alternatives before prescribing opioids, S2611 seeks to mitigate the risks associated with opioid usage, aligning with broader public health initiatives aimed at combating addiction and prescription drug abuse.

Summary

Bill S2611, introduced in the Rhode Island General Assembly, focuses on health and safety regarding opioid alternatives. It mandates that the Department of Health create and publish an educational pamphlet detailing non-opioid pain management options. The aim is to provide patients and healthcare practitioners with information on available alternatives for treating pain, emphasizing the importance of self-determination in healthcare decisions and the right to refuse opioid drugs.

Contention

Notable points of contention may arise as the bill's requirements for healthcare practitioners could lead to concerns about the burden placed on providers in prescribing protocols. There is a possibility that some factions in the medical community may view the mandated educational pamphlets and discussions as an inconvenience, potentially impacting patient care delivery. Moreover, the effectiveness of educational materials in influencing patient choices and outcomes could be debated, questioning the bill's actual impact on reducing opioid dependency.

Companion Bills

No companion bills found.

Similar Bills

NJ A3342

Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven day supply, except in certain circumstances.

NJ A2191

Increases amount allowed in initial prescription for opioid drugs in cases of acute pain.

CA AB1998

Opioids: safe prescribing policy.

NJ A2260

Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.

NJ A3630

Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.

TX HB2174

Relating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.

NJ A2731

Expands prescription monitoring program to include veterinarians.

CT SB00511

An Act Concerning Opioids.